期刊文献+

多索茶碱联合复方异丙托溴铵治疗支气管哮喘疗效 被引量:3

Efficacy of Doxofylline Combined with Ipratropium Bromide in the Treatment of Bronchial Asthma
下载PDF
导出
摘要 目的:探究多索茶碱联合复方异丙托溴铵治疗支气管哮喘的疗效及对患者血清细胞因子的影响。方法:选取我院收治的支气管哮喘患者86例,按随机数字表法分为对照组和观察组,各43例。对照组接受复方异丙托溴铵气雾剂(2.5 mg,tid)治疗,在此基础上,观察组加施多索茶碱(200 mg,bid)治疗。比较两组治疗效果、血清细胞因子、动脉血气及肺功能指标水平。结果:观察组总有效率高于对照组,差异有统计学意义(P <0.05);治疗后,观察组白细胞介素(IL)-5低于对照组,IL-12高于对照组,差异有统计学意义(P <0.05);观察组动脉血氧分压(PaO2)高于对照组,动脉血二氧化碳分压(PaCO2)低于对照组,差异有统计学意义(P <0.05);观察组用力肺活量(FVC)、一秒用力呼气容积(FEV1)和呼气峰流速(PEF)均高于对照组,差异有统计学意义(P <0.05)。结论:多索茶碱联合复方异丙托溴铵治疗支气管哮喘的疗效显著,可有效改善患者的肺功能及动脉血气,纠正体内Thl/Th2失衡,值得临床推荐。 Objective:To investigate the efficacy of doxofylline combined with ipratropium bromide in the treatment of bronchial asthma and its effect on serum cytokines.Methods:86 patients with bronchial asthma admitted to our hospital were selected and randomly divided into a control group and an observation group,43 cases each.The patients in the control group were treated with compound ipratropium bromide aerosol(2.5 mg,tid).On this basis,the patients in the observation group were treated with doxofylline(200 mg,bid).The therapeutic effect,serum cytokines,arterial blood gas and lung function indexes were compared between the two groups.Results:The total effective rate in the observation group was higher than that in the control group,and the difference was statistically significant(P<0.05).After treatment,the level of interleukin(IL)-5 in the observation group was lower than that in the control group,while the level of IL-12 was higher than that in the control group,with statistically significant differences(P<0.05).The arterial partial pressure of oxygen in the observation group(PaO2)was higher than that in the control group,while the arterial partial pressure of carbon dioxide(PaCO2)was lower than that in the control group,with statistically significant differences(P<0.05).The forced vital capacity(FVC),forced expiratory volume in one second(FEV1)and peak expiratory flow(PEF)in the observation group were higher than those in the control group,and the differences were statistically significant(P<0.05).Conclusion:Doxofylline combined with ipratropium bromide is significantly effective in the treatment of bronchial asthma,which can effectively improve the lung functions and arterial blood gas of the patients and correct the imbalance of Th1/Th2 in the bodies,which is worthy of clinical recommendation.
作者 肖延民 Xiao Yan-min(Department of Pharmacy,Luoyang Third People’s Hospital,Luoyang Henan 471002,China)
出处 《中国合理用药探索》 CAS 2019年第7期148-150,153,共4页 Chinese Journal of Rational Drug Use
关键词 多索茶碱 复方异丙托溴铵 支气管哮喘 Doxofylline Compound Ipratropium Bromide Bronchial Asthma
  • 相关文献

二级参考文献73

  • 1刘光辉,王忠喜,黄爱霞,祝戎飞,李文静,张威,陈欢.变应原疫苗对变态反应性鼻炎、支气管哮喘患者血清中TIgE及IgG水平的影响[J].药物流行病学杂志,2004,13(4):175-177. 被引量:3
  • 2李宏杰,康淑兰,李俐.支气管哮喘的药物治疗进展[J].药物流行病学杂志,2005,14(5):272-275. 被引量:15
  • 3Rajanandh MG,Nageswari AD,Ilango K.Assessment of montelukast,doxofylline,and tiotropium with budesonide for the treatment of asthma: which is the best among the second-line treatment? A Randomized Trial[J].Clin Ther,2015,37(2):418-26.
  • 4Edelen MO.Correspondence between the RAND-negative impact of asthma on quality of life item bank and the marks asthma quality of life questionnaire[J].Clin Ther,2014,36(5):680-688.
  • 5Hasegawa S.Cytokine profile of bronchoalveolar lavage fluid from a mouse model of bronchial asthma during seasonal H1N1 infection[J].Cytokine,2014,69(2):206-210.
  • 6Pin I,Gibson PG,Kolendowicz R,et al.Use of induced sputum cell counts to investigate airway inflammation in asthma[J].Thorax,1992,47(1):25-29.
  • 7Labre M P, Herman E J, Dumitru G G, et al. Public health interventions for asthma: an umbrella review, 1990-2010 [J]. Am J Prev Med., 2012, 42(4): 403-410.
  • 8Rank M A, Hagan J B, Park M A, et al. The risk of asthma exacerbation after stopping low-dose inhaled corticosteroids: a systematic review and meta-analysis of randomized controlled trials [J]. J Allergy Clin Immunol, 2013, 131(3): 724-729.
  • 9Margay S M, Farhat S, Kaur S, et al. To study the efficacy and safety of doxophylline and theophylline in bronchial asthma [J]. J Clin Diagn Res, 2015, 9(4): FC05-FC8.
  • 10Melosini L, Dente F L, Bacci E, et al. Asthma control test (ACT): comparison with clinical, functional, and biological markers of asthma control [J]. J Asthma, 2012, 49(3): 317-323.

同被引文献28

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部